Skip to main content

International Journal of Hematology

Ausgabe 5/2020

Inhalt (24 Artikel)

Images in Hematology

Stealth thrombosis of brain and kidney in a girl with Upshaw–Schulman syndrome not receiving prophylactic plasma infusions

Saori Tanabe, Yoshihiro Fujimura, Bernhard Lämmle, Toshiyuki Kimura, Ayami Isonishi, Kazuya Sakai, Masanori Matsumoto

Images in Hematology

Auer-bodies in cellular components other than typical myeloblasts

Tohru Inaba, Taku Tsukamoto, Naohisa Fujita, Junya Kuroda

Rapid Communication

Secondary failure of platelet recovery in patients treated with high-dose thiotepa and busulfan followed by autologous stem cell transplantation

Fumiya Wada, Momoko Nishikori, Masakatsu Hishizawa, Mitsumasa Watanabe, Akiko Aiba, Toshiyuki Kitano, Yayoi Shimazu, Takero Shindo, Tadakazu Kondo, Akifumi Takaori-Kondo

Guideline

Expert consensus regarding standardization of sample preparation for clotting time assays

Masahiro Ieko, Yutaka Komiyama, Satoshi Yamazaki, Hisako Katagiri, Chisato Shimazu, Sumiyoshi Naito, Masato Matsuda, Yoichi Yuki, Kazuyoshi Miyata, Rika Arai, Osamu Kumano, Mari Emmi, Tatsuya Yoshida, Hideaki Tanaka, Toshihiko Okuhara, Tetsuji Yamashita, Yasuji Sekine, Masaru Homma, Yohko Kawai, Kaoru Tohyama, Masahiro Ieko, Yutaka Komiyama, Satoshi Yamazaki, Hisako Katagiri, Chisato Shimazu, Sumiyoshi Naito, Masato Matsuda, Yoichi Yuki, Kazuyoshi Miyata, Rika Arai, Osamu Kumano, Mari Emmi, Tatsuya Yoshida, Hideaki Tanaka, Toshihiko Okuhara, Tetsuji Yamashita, Yasuji Sekine, Masaru Homma, Yohko Kawai, Kaoru Tohyama

Original Article

A modified thrombin generation assay to evaluate the plasma coagulation potential in the presence of emicizumab, the bispecific antibody to factors IXa/X

Kenichi Ogiwara, Keiji Nogami, Naoki Matsumoto, Mariko Noguchi-Sasaki, Michinori Hirata, Tetsuhiro Soeda, Midori Shima

Original Article

Prevalence and risk factors of high echocardiographic probability of pulmonary hypertension in myeloproliferative neoplasms patients

Yanika Jindamai, Ekarat Rattarittamrong, Arintaya Phrommintikul, Lalita Yongsmith, Pokpong Piriyakhuntorn, Thanawat Rattanathammethee, Sasinee Hantrakool, Chatree Chai-Adisaksopha, Adisak Tantiworawit, Lalita Norasetthada

Original Article

Pembrolizumab plus lenalidomide and dexamethasone in treatment-naive multiple myeloma (KEYNOTE-185): subgroup analysis in Japanese patients

Naoki Takezako, Hiroshi Kosugi, Morio Matsumoto, Shinsuke Iida, Takayuki Ishikawa, Yukio Kondo, Kiyoshi Ando, Hirokazu Miki, Itaru Matsumura, Kazutaka Sunami, Takanori Teshima, Hiromi Iwasaki, Yasushi Onishi, Masahiro Kizaki, Koji Izutsu, Dai Maruyama, Kensei Tobinai, Razi Ghori, Mohammed Farooqui, Jason Liao, Patricia Marinello, Kenji Matsuda, Yasuhiro Koh, Takashi Shimamoto, Kenshi Suzuki

Original Article

Development of diffuse large B-cell lymphoma from duodenal type follicular lymphoma: a retrospective study of 23 cases

Masuho Saburi, Yoshiyuki Kondo, Masao Ogata, Yasuhiro Soga, Miyuki Abe, Kuniko Takano, Kazuhiro Kohno, Takayuki Nagai, Toshiyuki Nakayama

Original Article

Retrospective analysis of plasmacytoma in Kansai Myeloma Forum Registry

Aya Nakaya, Hirokazu Tanaka, Hideo Yagi, Kensuke Ohta, Hirohiko Shibayama, Takae Kohara, Junya Kanda, Maki Shindo, Yuji Shimura, Satoru Kosugi, Toru Kida, Hitomi Kaneko, Kazunori Imada, Takahiro Karasuno, Mitsuhiro Matsuda, Masato Iida, Yoko Adachi, Shin-ichi Fuchida, Nobuhiko Uoshima, Hitoji Uchiyama, Ryoichi Takahashi, Toshimitsu Matsui, Katsuya Wada, Miki Kiyota, Chihiro Shimazaki, Masayuki Hino, Junya Kuroda, Yuzuru Kanakura, Akifumi Takaori-Kondo, Shosaku Nomura, Itaru Matsumura

Original Article

Safety and efficacy of anti-programmed cell death-1 monoclonal antibodies before and after allogeneic hematopoietic cell transplantation for relapsed or refractory Hodgkin lymphoma: a multicenter retrospective study

Ayumu Ito, Sung-Won Kim, Ken-ichi Matsuoka, Toshiro Kawakita, Takashi Tanaka, Yoshihiro Inamoto, Tomomi Toubai, Shin-ichiro Fujiwara, Masafumi Fukaya, Tadakazu Kondo, Junichi Sugita, Miho Nara, Yuna Katsuoka, Yosuke Imai, Hideyuki Nakazawa, Ichiro Kawashima, Rika Sakai, Arata Ishii, Makoto Onizuka, Tomonari Takemura, Seitaro Terakura, Hiroatsu Iida, Mika Nakamae, Kohei Higuchi, Shinobu Tamura, Satoshi Yoshioka, Kazuto Togitani, Noriaki Kawano, Ritsuro Suzuki, Junji Suzumiya, Koji Izutsu, Takanori Teshima, Takahiro Fukuda

Original Article

An analysis of oral microbial flora by T-RFLP in patients undergoing hematopoietic stem cell transplantation

Miho Takahashi, Masako Toyosaki, Keiko Matsui, Shinichiro Machida, Eri Kikkawa, Yoshihide Ota, Akihiro Kaneko, Yoshiaki Ogawa, Kiyoshi Ando, Makoto Onizuka

Original Article

Clinical usefulness of diagnostic criteria for transplant-associated thrombotic microangiopathy

Ken Sagou, Nobuaki Fukushima, Shun Ukai, Miyo Goto, Kazutaka Ozeki, Akio Kohno

Original Article

Functional analysis of a novel fusion protein PAX5-KIDINS220 identified in a pediatric Ph-like ALL patient

Takuyo Kanayama, Toshihiko Imamura, Azusa Mayumi, Emi Soma, Kenichi Sakamoto, Fumihiko Hayakawa, Akihiko Tanizawa, Nobutaka Kiyokawa, Hajime Hosoi

Original Article

FLEND (nelarabine, fludarabine, and etoposide) for relapsed T-cell acute lymphoblastic leukemia in children: a report from Japan Children’s Cancer Group

Tadashi Kumamoto, Hiroaki Goto, Chitose Ogawa, Toshinori Hori, Takao Deguchi, Takuya Araki, Akiko M. Saito, Atsushi Manabe, Keizo Horibe, Hidemi Toyoda

Case Report

Myelodysplastic syndromes in a pediatric patient with Cri du Chat syndrome with a ring chromosome 5

Akifumi Nozawa, Michio Ozeki, Shiho Yasue, Saori Endo, Tomonori Kadowaki, Hidenori Ohnishi, Hideki Muramatsu, Asahito Hama, Yoshiyuki Takahashi, Seiji Kojima, Toshiyuki Fukao

Case Report

HHV8-positive, EBV-positive Hodgkin lymphoma-like large B cell lymphoma: expanding the spectrum of HHV8 and EBV-associated lymphoproliferative disorders

Sandra Sanchez, Luis Veloza, Luojun Wang, Mónica López, Armando López-Guillermo, Marta Marginet, Antonio Martínez, Olga Balagué, Elias Campo

Case Report

Diagnosis of a difficult to differentiate case of early-onset hyperviscosity syndrome caused by IgM type multiple myeloma: a case report

Takuro Yoshimura, Yoshiki Hayashi, Katsujun Shimizu, Naoko Yagi, Minako Tsutsumi, Yosuke Nakaya, Hoyuri Fuseya, Mirei Horiuchi, Masahiro Yoshida, Takafumi Nakao, Takeshi Inoue, Takahisa Yamane

Zur Zeit gratis COVID-19 Case Report

Severe immune thrombocytopenic purpura in critical COVID-19

Valérie Lévesque, Émilie Millaire, Daniel Corsilli, Benjamin Rioux-Massé, François-Martin Carrier

Case Report

A case of human herpesvirus 6 encephalitis following pediatric hematopoietic stem cell transplantation: early diagnosis and treatment matters

Atsushi Sakamoto, Masaki Yamada, Shin-ichi Tsujimoto, Tomoo Osumi, Katsuhiro Arai, Daisuke Tomizawa, Akira Ishiguro, Kimikazu Matsumoto, Ken-Ichi Imadome, Motohiro Kato

Letter to the Editor

Seroprevalence of Toxoplasma gondii among Japanese adults with hematological diseases

Takehiko Mori, Kei Mikita, Yuya Koda, Masatoshi Sakurai, Masuho Saburi, Naoki Hasegawa, Jun Kato

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.